Comparison of Lumbar Muscle Thickness Measurements in Osteoporotic and Osteopenic Patients

NCT ID: NCT05823558

Last Updated: 2024-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

301 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-15

Study Completion Date

2024-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In osteoporosis, sarcopenia is a common condition. Sarcopenic measurements can be made by evaluating muscle thickness in different regions. We aim to evaluate lumbar muscle losses in patients with osteoporosis in the lumbar region and to examine whether these muscle losses are correlated with the level of osteoporosis. The patients will be divided into 3 groups as healthy, osteopenic and osteoporotic according to DEXA measurements. Demographic values, comorbidities, osteoporosis drugs used, fracture histories, L1-4, L2-4, femoral neck and total BMD and t values of the patients, psoas and multifidus muscle measurements will be made at L2-L3 level in Lumbar MR imaging. Lumbar MR muscle measurements will be made by 1 physician blind to the DEXA values of the patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ostoporotic Patients Group

T value of -2.5 and below in DEXA measurement

Lomber Muscle Thickness Measurement

Intervention Type DIAGNOSTIC_TEST

Muscle thickness measurements will be made on the imaging of those who have lumbar MR imaging.

Osteopenic Patients Group

T value between -2.5 and -1 in DEXA measurement

Lomber Muscle Thickness Measurement

Intervention Type DIAGNOSTIC_TEST

Muscle thickness measurements will be made on the imaging of those who have lumbar MR imaging.

Healthy Group

T value of -1 and above in DEXA measurement

Lomber Muscle Thickness Measurement

Intervention Type DIAGNOSTIC_TEST

Muscle thickness measurements will be made on the imaging of those who have lumbar MR imaging.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lomber Muscle Thickness Measurement

Muscle thickness measurements will be made on the imaging of those who have lumbar MR imaging.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 50-90 years old
* 2\. Recent MRI of the lumbar region with DEXA evaluation

Exclusion Criteria

* Have had previous lumbar surgery
* Any previous lumbar injection
* Stage 3-4 Lumbar Listesis
* Presence of Lumbar Discopathy accompanied by neurological deficit
Minimum Eligible Age

50 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aylin Ayyıldız

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Etfal Training and Research Hospital

Istanbul, Istanbul, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10042023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Osteoporosis After Stroke
NCT07059468 NOT_YET_RECRUITING
Osteosarcopenia and Exercise
NCT04526327 COMPLETED NA